FRENOVO Barbiturate (BAR) Rapid Test is a lateral flow, qualitative immunoassay. It is intended for qualitative detection of Secobarbital, a Barbiturate metabolite with a minimum detection concentration of 300 ng / ml in human urine samples, and for the preliminary screening detection of Barbiturate.
Clinical sensitivity = 99.33 %
Clinical specificity > 99.00 %
Accuracy= 99.67 %
Description：Barbiturate (BAR) Cassette
Method：GICA
Packing：20 Tests/Box
Specimen：Urine
English
